Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations - PubMed (original) (raw)
Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations
D Taylor et al. Hum Pathol. 1999 Oct.
Free article
Abstract
The genetic and functional status of the p53 gene may be an important factor in guiding therapeutic strategies for patients with cancer. The purpose of this study was to determine whether p53 immunohistochemistry (IHC) accurately reflects the mutational status of the p53 gene and to determine whether p53 IHC independently predicts tumor responsiveness to radiation therapy for patients with HNSCC. p53 IHC was performed using the monoclonal antibody DO7 on tumors from 85 patients with HNSCC treated with primary or adjuvant radiation. The p53 status in all of these tumors was previously assessed by direct sequence analysis of exons 5 through 9: 49 tumors were p53 wild-type, and 36 harbored p53 gene mutations. All patients were well characterized with respect to locoregional recurrence, distant spread, and survival. Positive p53 staining was observed in 53 of the 85 cases (62%). Only 27 (51%) of these 53 IHC-positive cases harbored gene mutations in exons 5 through 9; 23 (72%) of the 32 IHC-negative cases did not harbor mutations. The overall correlation rate between IHC and sequencing was 59% (P < .04, chi2). Discordant results were observed for 35 (41%) cases, including 26 IHC-positive cases and 9 IHC-negative cases. In 7 of 9 cases, false-negative staining was due to a nonsense or splice-site mutation. p53 IHC was not predictive of overall survival (P = .37) or disease-free survival (P = .95). In a sizable number of cases, p53 IHC does not reflect the mutational status of the p53 gene. Specific types of alterations (eg, truncating mutations) and other factors may contribute to this poor correlation. Moreover, p53 IHC does not appear to be an independent predictor of tumor responsiveness to radiation in patients with HNSCC.
Similar articles
- Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations.
Xu L, Chen YT, Huvos AG, Zlotolow IM, Rettig WJ, Old LJ, Garin-Chesa P. Xu L, et al. Diagn Mol Pathol. 1994 Jun;3(2):83-92. doi: 10.1097/00019606-199406000-00004. Diagn Mol Pathol. 1994. PMID: 8061893 - Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM. Westra WH, et al. Clin Cancer Res. 2008 Jan 15;14(2):366-9. doi: 10.1158/1078-0432.CCR-07-1402. Clin Cancer Res. 2008. PMID: 18223210 - Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
Kropveld A, Rozemuller EH, Leppers FG, Scheidel KC, de Weger RA, Koole R, Hordijk GJ, Slootweg PJ, Tilanus MG. Kropveld A, et al. Lab Invest. 1999 Mar;79(3):347-53. Lab Invest. 1999. PMID: 10092071 - The p53 network in head and neck cancer.
Gasco M, Crook T. Gasco M, et al. Oral Oncol. 2003 Apr;39(3):222-31. doi: 10.1016/s1368-8375(02)00163-x. Oral Oncol. 2003. PMID: 12618194 Review. - Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.
Beck TN, Smith CH, Flieder DB, Galloway TJ, Ridge JA, Golemis EA, Mehra R. Beck TN, et al. Head Neck. 2017 Mar;39(3):E34-E39. doi: 10.1002/hed.24604. Epub 2016 Nov 8. Head Neck. 2017. PMID: 27859938 Free PMC article. Review.
Cited by
- Unraveling the molecular genetics of head and neck cancer through genome-wide approaches.
Riaz N, Morris LG, Lee W, Chan TA. Riaz N, et al. Genes Dis. 2014 Sep;1(1):75-86. doi: 10.1016/j.gendis.2014.07.002. Genes Dis. 2014. PMID: 25642447 Free PMC article. - Implications of p53 protein upregulation in oral lichen planus: a systematic review and meta-analysis.
Keim-Del Pino C, Ramos-García P, Pimenta-Barros LA, González-Moles MÁ. Keim-Del Pino C, et al. Med Oral Patol Oral Cir Bucal. 2024 Nov 1;29(6):e832-e842. doi: 10.4317/medoral.26808. Med Oral Patol Oral Cir Bucal. 2024. PMID: 39396145 Free PMC article. - TP53 mutations and survival in squamous-cell carcinoma of the head and neck.
Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, Califano JA, Ridge JA, Goodwin J, Kenady D, Saunders J, Westra W, Sidransky D, Koch WM. Poeta ML, et al. N Engl J Med. 2007 Dec 20;357(25):2552-61. doi: 10.1056/NEJMoa073770. N Engl J Med. 2007. PMID: 18094376 Free PMC article. - Prevalence of p53 dysregulations in feline oral squamous cell carcinoma and non-neoplastic oral mucosa.
Renzi A, De Bonis P, Morandi L, Lenzi J, Tinto D, Rigillo A, Bettini G, Bellei E, Sabattini S. Renzi A, et al. PLoS One. 2019 Apr 18;14(4):e0215621. doi: 10.1371/journal.pone.0215621. eCollection 2019. PLoS One. 2019. PMID: 30998743 Free PMC article. - Relationship among tobacco habits, human papilloma virus (HPV) infection, p53 polymorphism/mutation and the risk of oral squamous cell carcinoma.
Chakrobarty B, Roy JG, Majumdar S, Uppala D. Chakrobarty B, et al. J Oral Maxillofac Pathol. 2014 May;18(2):211-6. doi: 10.4103/0973-029X.140752. J Oral Maxillofac Pathol. 2014. PMID: 25328301 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous